+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Contraceptive Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4829811
  • Report
  • Region: Global
  • 144 pages
  • 360iResearch
1 of 3

FEATURED COMPANIES

  • Agile Therapeutics
  • Ani Pharmaceuticals Inc.
  • Church & Dwight Co., Inc.
  • Fuji Latex Co. Ltd
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
The Global Contraceptive Market is expected to grow from USD 32567.26 Millions in 2018 to USD 105998.56 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 18.36%.

Growing incidence of unwanted pregnancies and sexually transmitted diseases is one of the factors largely attributing to the growth of the Global Contraceptive Market

The factors attributing to the growth of the market are Easy of availability of various contraceptives, such as of contraceptive pills and condoms, Growing incidence of unwanted pregnancies and sexually transmitted diseases, Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population, and Popularity of oral contraceptive pills in women of reproductive age. However, some factors such as Side effects of oral contraceptive drugs may hinder the market growth. The Global Contraceptive Market is expected to showcase the opportunities such as Growth opportunities for affordable contraceptives method such as Sino-Implants and novel contraceptive and Government and non-government organizations supporting programs to encourage contraception in emerging economies. In the near future market may face the possible challenges in the growth due to Lack of information and misconceptions about different contraceptives. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Global Contraceptive Market.

On the basis of Drugs, the Global Contraceptive Market is studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.

On the basis of Gender, the Global Contraceptive Market is studied across Female Contraceptive Devices and Male Contraceptive Devices.

On the basis of Distribution, the Global Contraceptive Market is studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.

Allergan Plc the potential growing player for the Global Contraceptive Market

The key players profiled in the Global Contraceptive Market are Allergan Plc, Veru Inc., Ani Pharmaceuticals Inc., Church & Dwight Co., Inc., Teva Pharmaceuticals Industries Ltd., Gilead Sciences Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Agile Therapeutics, Johnson & Johnson, Merck & Co. Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Bayer Corporation, and Mayer Laboratories, Inc..

The report covers two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model
derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Contraceptive Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Contraceptive Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Contraceptive Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Contraceptive Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Contraceptive Market

The report answers questions such as:

1. What is the market size of Contraceptive market in the Global?
2. What are the factors that affect the growth in the Global Contraceptive Market over the forecast period?
3. What is the competitive position in the Global Contraceptive Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Contraceptive Market?
5. What are the opportunities in the Global Contraceptive Market?
6. What are the modes of entering the Global Contraceptive Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agile Therapeutics
  • Ani Pharmaceuticals Inc.
  • Church & Dwight Co., Inc.
  • Fuji Latex Co. Ltd
  • Johnson & Johnson
  • Merck & Co. Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Contraceptive Market
3.2. Opportunities in the Contraceptive Market
3.3. Geographical Analysis in the Contraceptive Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
4.2.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
4.2.1.3. Popularity of oral contraceptive pills in women of reproductive age
4.2.1.4. Easy of availability of various contraceptives, such as of contraceptive pills and condoms
4.2.2. Restraints
4.2.2.1. Side effects of oral contraceptive drugs
4.2.3. Opportunities
4.2.3.1. Government and non-government organizations supporting programs to encourage contraception in emerging economies
4.2.3.2. Growth opportunities for affordable contraceptives method such as Sino-Implants and novel contraceptive
4.2.4. Challenges
4.2.4.1. Lack of information and misconceptions about different contraceptives
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Contraceptive Market, by Drugs
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Contraceptive Injectable
5.4. Emergency Contraceptive Pills
5.5. Oral Contraceptives
5.6. Transdermal Patches

6. Global Contraceptive Market, by Gender
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Female Contraceptive Devices
6.4. Male Contraceptive Devices

7. Global Contraceptive Market, by Distribution
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Clinics
7.4. Hospital Pharmacy
7.5. Independent Pharmacy
7.6. Online Platform

8. Americas Contraceptive Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Canada
8.4. Mexico
8.5. United States

9. Asia-Pacific Contraceptive Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. China
9.4. India
9.5. Japan

10. Europe, Middle East & Africa Contraceptive Market Estimates & Trend Analysis
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. France
10.4. Germany
10.5. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix for Global Contraceptive Market
11.2. Market Vendor Ranking Analysis for Global Contraceptive Market
11.3. Competitive News Feed Analysis for Global Contraceptive Market
11.3.1. Mergers & Acquisitions
11.3.2. New Product Launches
11.3.3. Business Expansions
11.3.4. Partnerships, Agreements & Collaborations

12. Company Usability Profiles
12.1. Allergan Plc
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.1.4. Scorecard
12.2. Bayer Corporation
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.2.4. Scorecard
12.3. Church & Dwight Co., Inc.
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.3.4. Scorecard
12.4. CooperSurgical, Inc.
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.4.4. Scorecard
12.5. Mayer Laboratories, Inc.
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.5.4. Scorecard
12.6. Agile Therapeutics
12.6.1. Overview
12.6.2. Strategy
12.6.3. SWOT
12.6.4. Scorecard
12.7. Ani Pharmaceuticals Inc.
12.7.1. Overview
12.7.2. Strategy
12.7.3. SWOT
12.7.4. Scorecard
12.8. Fuji Latex Co. Ltd
12.8.1. Overview
12.8.2. Strategy
12.8.3. SWOT
12.8.4. Scorecard
12.9. Gilead Sciences Inc.
12.9.1. Overview
12.9.2. Strategy
12.9.3. SWOT
12.9.4. Scorecard
12.10. Johnson & Johnson
12.10.1. Overview
12.10.2. Strategy
12.10.3. SWOT
12.10.4. Scorecard
12.11. Merck & Co. Inc.
12.11.1. Overview
12.11.2. Strategy
12.11.3. SWOT
12.11.4. Scorecard
12.12. Pfizer Inc
12.12.1. Overview
12.12.2. Strategy
12.12.3. SWOT
12.12.4. Scorecard
12.13. Reckitt Benckiser Group Plc
12.13.1. Overview
12.13.2. Strategy
12.13.3. SWOT
12.13.4. Scorecard
12.14. Teva Pharmaceuticals Industries Ltd.
12.14.1. Overview
12.14.2. Strategy
12.14.3. SWOT
12.14.4. Scorecard
12.15. Veru Inc.
12.15.1. Overview
12.15.2. Strategy
12.15.3. SWOT
12.15.4. Scorecard

13. Appendix
13.1. Discussion Guide
13.2. Top Reports
13.2.1. Global Gastrointestinal Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.2. Global Polymer Matrix Composites Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.3. Global Policy Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.2.4. Global Smart Waste Management Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
13.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Bayer Corporation
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Mayer Laboratories, Inc.
  • Agile Therapeutics
  • Ani Pharmaceuticals Inc.
  • Fuji Latex Co. Ltd
  • Gilead Sciences Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • Veru Inc.
Note: Product cover images may vary from those shown
Adroll
adroll